Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of sevuparin for acute vaso-occlusive crisis in sickle cell disease
2014-004416-11Phase 2Completed
- Sponsor
- Modus Therapeutics
- Start
- Apr 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vaso-occlusive crisis (VOC) and sickle cell disease (SCD) comparing Sevuparin infusion with Placebo infusion (2 arms). Primary endpoint: Time to vaso-occlusive crisis resolution. Started Apr 2015; status: completed.
02
Drugs
sevuparin
03
Conditions
vaso-occlusive crisis (VOC)sickle cell disease (SCD)
Beyond the preview
Go deeper on 2014-004416-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004416-11.